674 related articles for article (PubMed ID: 31941015)
1. Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences.
Hong SH; Choi KM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31941015
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenic obesity.
Polyzos SA; Margioris AN
Hormones (Athens); 2018 Sep; 17(3):321-331. PubMed ID: 30014320
[TBL] [Abstract][Full Text] [Related]
3. The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease.
Kim TN; Choi KM
J Cell Biochem; 2015 Jul; 116(7):1171-8. PubMed ID: 25545054
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments.
Wang M; Tan Y; Shi Y; Wang X; Liao Z; Wei P
Front Endocrinol (Lausanne); 2020; 11():568. PubMed ID: 32982969
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
Asrih M; Jornayvaz FR
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
[TBL] [Abstract][Full Text] [Related]
6. The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials.
Consitt LA; Clark BC
J Frailty Aging; 2018; 7(1):21-27. PubMed ID: 29412438
[TBL] [Abstract][Full Text] [Related]
7. Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver.
Takamura T; Misu H; Ota T; Kaneko S
Endocr J; 2012; 59(9):745-63. PubMed ID: 22893453
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenic obesity in fatty liver.
Merli M; Lattanzi B; Aprile F
Curr Opin Clin Nutr Metab Care; 2019 May; 22(3):185-190. PubMed ID: 30893090
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review.
Armandi A; Rosso C; Caviglia GP; Ribaldone DG; Bugianesi E
Front Endocrinol (Lausanne); 2021; 12():716533. PubMed ID: 34858322
[TBL] [Abstract][Full Text] [Related]
10. Potential mechanisms of muscle mitochondrial dysfunction in aging and obesity and cellular consequences.
Chanséaume E; Morio B
Int J Mol Sci; 2009 Jan; 10(1):306-324. PubMed ID: 19333447
[TBL] [Abstract][Full Text] [Related]
11. Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease.
Iwaki M; Kobayashi T; Nogami A; Saito S; Nakajima A; Yoneda M
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839249
[TBL] [Abstract][Full Text] [Related]
12. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity.
Chung JY; Kang HT; Lee DC; Lee HR; Lee YJ
Arch Gerontol Geriatr; 2013; 56(1):270-8. PubMed ID: 23079031
[TBL] [Abstract][Full Text] [Related]
13. Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus.
Koliaki C; Roden M
Annu Rev Nutr; 2016 Jul; 36():337-67. PubMed ID: 27146012
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities.
Cleasby ME; Jamieson PM; Atherton PJ
J Endocrinol; 2016 May; 229(2):R67-81. PubMed ID: 26931135
[TBL] [Abstract][Full Text] [Related]
15. Exercise Therapy for People With Sarcopenic Obesity: Myokines and Adipokines as Effective Actors.
Alizadeh Pahlavani H
Front Endocrinol (Lausanne); 2022; 13():811751. PubMed ID: 35250869
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis.
Kalinkovich A; Livshits G
Ageing Res Rev; 2017 May; 35():200-221. PubMed ID: 27702700
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Ageing- and Diet-Related Swine Models of Sarcopenia and Sarcopenic Obesity.
Garcia-Contreras C; Vazquez-Gomez M; Torres-Rovira L; Gonzalez J; Porrini E; Gonzalez-Colaço M; Isabel B; Astiz S; Gonzalez-Bulnes A
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534532
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol prevents sarcopenic obesity by reversing mitochondrial dysfunction and oxidative stress via the PKA/LKB1/AMPK pathway.
Huang Y; Zhu X; Chen K; Lang H; Zhang Y; Hou P; Ran L; Zhou M; Zheng J; Yi L; Mi M; Zhang Q
Aging (Albany NY); 2019 Apr; 11(8):2217-2240. PubMed ID: 30988232
[TBL] [Abstract][Full Text] [Related]
19. The role of weight loss and exercise in correcting skeletal muscle mitochondrial abnormalities in obesity, diabetes and aging.
Toledo FG; Goodpaster BH
Mol Cell Endocrinol; 2013 Oct; 379(1-2):30-4. PubMed ID: 23792186
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies.
Stefan N; Häring HU; Cusi K
Lancet Diabetes Endocrinol; 2019 Apr; 7(4):313-324. PubMed ID: 30174213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
